ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma

T. Powles, J. Bellmunt, E. Comperat,M. De Santis, R. Huddart, Y. Loriot, A. Necchi, B.P. Valderrama, A. Ravaud, S.F. Shariat, B. Szabados,M.S. van der Heijden, S. Gillessen

Annals of Oncology（2024）

引用 0|浏览2

暂无评分

关键词

bladder cancer,enfortumab vedotin,fibroblast growth factor receptor inhibitor,nivolumab,pembrolizumab,urothelial carcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要